Latest Breaking News On - Prasad devarajan - Page 1 : comparemela.com

FDA Clears First Test to Identify Hospitalized Children at

FDA Clears First Test to Identify Hospitalized Children at
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesRajit basuPrasad devarajanStuartl goldsteinAmerican kidney associationDrug administrationFirst testIdentify hospitalized childrenAcute kidney injuryCincinnati childrenNasdaq copenhagen

BioPorto Receives FDA 510(k) Clearance for NGAL Test in the

BioPorto Receives FDA 510(k) Clearance for NGAL Test in the
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesAshleyr robinsonPrasad devarajanDrug administrationBioporto company announcementsGlobal press relationsPatients agedAcute kidney injuryTony pareChief executiveSenior medical directorDevelopmental biologyDialysis unitCincinnati childrenHospital medicalRoche diagnostics gmbh

BioPorto Receives FDA 510(k) Clearance for NGAL Test in the United States First Test to Aid in Assessing AKI Risk for Patients Aged 3 Months Through 21 Years -December 07, 2023 at 04:23 pm EST

December 7, 2023 Announcement no. 20 BioPorto Receives FDA 510 Clearance for NGAL Test in the United StatesFirst Test to Aid in Assessing AKI Risk for Patients Aged 3 Months Through 21 Years .

United statesAshleyr robinsonPrasad devarajanGlobal press relationsDrug administrationBioporto company announcementsPatients agedAcute kidney injuryTony pareChief executiveSenior medical directorDevelopmental biologyDialysis unitCincinnati childrenHospital medicalRoche diagnostics gmbh

BioPorto Announces Interim Results for the First Six Months of 2022

17.08.2022 - COPENHAGEN, Denmark and BOSTON, Aug. 17, 2022 (GLOBE NEWSWIRE) - BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced interim financial results for the first six months of 2022 and business progress for the second quarter of 2022. Recent .

United statesPrasad devarajanAshley robinsonTim eriksenCompany guidanceDanish society of financial analystsDrug administrationDanish financial supervisory authoritySenior medical directorVincenza courseChief executive officerEuropean timeZenith advisoryLifesci advisorsAcute kidney injuryNasdaq copenhagen

BioPorto Announces Interim Results for the First Six Months

August 17, 2022Announcement no. 13 BioPorto Announces Interim Results for the First Six Months of 2022 COPENHAGEN, DENMARK and BOSTON, MA, USA, August.

United statesPrasad devarajanAshley robinsonBioportoas bioportoTim eriksenCompany guidanceDrug administrationDanish financial supervisory authorityPorto announces interim resultsFirst six monthsSenior medicalVincenza courseChief executive officerEuropean timeZenith advisoryLifesci advisors